Recent Finacing
Recent Raise
TORL BioTherapeutics is a Los-Angeles–based clinical-stage biotech developing antibody-drug conjugates and other antibody therapies for CLDN6-positive cancers.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at TORL BioTherapeutics.
